Novel Therapy 4
NOVEL THERAPY Clinical trial leads to new melanoma drug Groundbreaking new drug approved by the FDA. Read Story
NOVEL THERAPY Clinical trial leads to new melanoma drug Groundbreaking new drug approved by the FDA. Read Story
NOVEL THERAPY Dramatic response to clinical trial for stage 4 lung cancer Patient remains cancer-free more than three years after treatment. Read Story
NOVEL THERAPY Researchers improve immunotherapy technique New diagnostics could increase precision of existing therapies. Read Story
NOVEL THERAPY Mask cancer drug reduces side-effects New immunotherapy would activate on contact with tumors. Read Story
Communities around the globe face the challenge of delivering high-quality healthcare while managing skyrocketing healthcare expenses. The Cyrus Tang Foundation recently awarded a three-year, $900,000 grant to the University of
ADAPTIVE ONCOLOGY AI trained to predict immunotherapy outcomes Researchers aim to tailor treatments for lung cancer patients. Read Story
ADAPTIVE ONCOLOGY Clinical trial targets chemotherapy-resistant cancer Ovarian cancer patient sees rapid improvement on new drug. Read Story
ADAPTIVE ONCOLOGY AI software aids breast cancer diagnosis Software wins Best Inventions award for 2019. Read Story